{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-070212","form_type":"8-K","ticker":"SILO","cik":"0001514183","company_name":"Silo Pharma, Inc.","filed_at":"2026-06-18T21:15:27+00:00","discovered_at":"2026-06-18T21:16:00.270012+00:00","generated_at":"2026-06-18T21:16:46.986257+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Silo Pharma regains compliance with Nasdaq minimum bid price rule","bullets":["Received Nasdaq confirmation on June 17, 2026, that it regained compliance with Listing Rule 5550(a)(2).","Closing bid price was $1.00 or greater from June 3 to June 16, 2026, satisfying the requirement.","Nasdaq considers the matter closed; SILO continues trading on the Nasdaq Capital Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-070212","json":"https://secwatch.observer/filing/0001213900-26-070212.json","markdown":"https://secwatch.observer/filing/0001213900-26-070212.md","text":"https://secwatch.observer/filing/0001213900-26-070212.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1514183/000121390026070212/0001213900-26-070212-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1514183/000121390026070212/ea0295339-8k_silo.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T21:16:46.986257+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}